We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
+19.23%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$1.08B
AUM Growth
+$128M
Cap. Flow
-$13.4M
Cap. Flow %
-1.24%
Top 10 Hldgs %
65.89%
Holding
283
New
55
Increased
41
Reduced
42
Closed
144

Sector Composition

Rank Sector Weight
1 Healthcare 60.27%
2 Real Estate 10.75%
3 Technology 10.08%
4 Industrials 8.07%
5 Consumer Discretionary 3.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNDX icon
226
Syndax Pharmaceuticals
SNDX
$1.69B
-35,027
Closed -$246K
SRPT icon
227
Sarepta Therapeutics
SRPT
$1.57B
-14,160
Closed -$1.87M
SSNC icon
228
SS&C Technologies
SSNC
$18.6B
-56,247
Closed -$2.92M
STT icon
229
State Street
STT
$50.6B
-10,508
Closed -$978K
SVRA icon
230
Savara
SVRA
$1.12B
-75,099
Closed -$850K
TRI icon
231
Thomson Reuters
TRI
$42.8B
-98,296
Closed -$4.6M
TT icon
232
Trane Technologies
TT
$101B
-38,008
Closed -$3.41M
UAL icon
233
United Airlines
UAL
$39.4B
-45,408
Closed -$3.17M
UNM icon
234
Unum
UNM
$13.6B
-35,611
Closed -$1.32M
VOYA icon
235
Voya Financial
VOYA
$9.01B
-44,476
Closed -$2.09M
WTW icon
236
Willis Towers Watson
WTW
$31.7B
-59,324
Closed -$8.99M
XLF icon
237
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
-150,911
Closed -$4.01M
PDCO
238
DELISTED
Patterson Companies, Inc.
PDCO
-22,141
Closed -$502K
SLCA
239
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
-19,251
Closed -$495K
DSKE
240
DELISTED
Daseke, Inc. Common Stock
DSKE
-66,714
Closed -$662K
VMW
241
DELISTED
VMware, Inc
VMW
-14,956
Closed -$2.2M
ICPT
242
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-31,248
Closed -$2.62M
RETA
243
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-26,439
Closed -$925K
NUVA
244
DELISTED
NuVasive, Inc.
NUVA
-26,890
Closed -$1.4M
KDNY
245
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-14,120
Closed -$494K
UNVR
246
DELISTED
Univar Solutions Inc.
UNVR
-159,394
Closed -$4.18M
SPPI
247
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
-49,743
Closed -$1.04M
PRTY
248
DELISTED
Party City Holdco Inc.
PRTY
-84,099
Closed -$1.28M
OTIC
249
DELISTED
Otonomy, Inc.
OTIC
-297,559
Closed -$1.15M
CLVS
250
DELISTED
Clovis Oncology, Inc.
CLVS
-11,744
Closed -$534K

Similar funds

Crestline Management's Q3 2018 Portfolio in Review

As of Q3 2018, Crestline Management held 283 positions worth $1.08B, up 13% from $952M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Crestline Management's Q3 2018 filing shows 55 new, 41 increased, 42 reduced and 144 closed positions. Its largest new stake was Aquestive Therapeutics: 11,503,294 shares worth $201M. The largest sale was Athene Holding Ltd. Class A Common Shares, an estimated $11.1M.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 43% a quarter earlier, followed by Real Estate and Technology.

  • Crestline Management's largest Q3 2018 buy was Aquestive Therapeutics: 11,503,294 shares worth $201M.
  • Crestline Management added most to Red Hat Inc in Q3 2018, an estimated $6.11M increase.
  • Crestline Management's biggest Q3 2018 reduction was Norwegian Cruise Line, cutting an estimated $4.27M.
  • Crestline Management fully exited Athene Holding Ltd. Class A Common Shares in Q3 2018, selling an estimated $11.1M.
  • Crestline Management's ten largest holdings make up 66% of its $1.08B portfolio in Q3 2018.
  • Crestline Management opened 55 new positions and closed 144 in Q3 2018.
  • Crestline Management's portfolio value rose 13% quarter-over-quarter to $1.08B.

Based on Crestline Management's 13F filing for Q3 2018, filed 14 Nov 2018.